Eventide Asset Management - SATSUMA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Eventide Asset Management ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$28,282,000
+37.5%
983,3820.0%0.62%
-7.7%
Q1 2020$20,562,000
+145.8%
983,382
+131.4%
0.67%
+182.2%
Q4 2019$8,364,000
+31.1%
425,0000.0%0.24%
+11.8%
Q3 2019$6,379,000425,0000.21%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,118,761$14,533,0003.83%
Ghost Tree Capital, LLC 904,225$4,214,0001.23%
RA Capital Management 5,914,252$27,560,0000.38%
Vivo Capital, LLC 1,232,394$5,743,0000.26%
Nan Fung Group Holdings Ltd 142,900$666,0000.21%
Ikarian Capital, LLC 629,384$2,934,0000.21%
NEA Management Company, LLC 3,142,958$14,646,0000.17%
SAMLYN CAPITAL, LLC 1,716,067$7,998,0000.11%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$8,788,0000.09%
GSA CAPITAL PARTNERS LLP 90,665$422,0000.04%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders